↓ Skip to Main Content

Thasso the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

search: thasso

Search for:

Main Navigation

english
- english
- français
- deutsch
- italiano
- español
- português
thasso
thasso post
thasso toolbox
thasso academy
thasso community
thasso: about
donations
- thasso – thank you
- Donation Confirmation

search: thasso

Search for:

Thasso the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

Off Canvas Menu

english
- english
- français
- deutsch
- italiano
- español
- português
thasso
thasso post
thasso toolbox
thasso academy
thasso community
thasso: about
donations
- thasso – thank you
- Donation Confirmation

patient & consumer health

thasso academy provides a space for expert advice and knowledge on prevention of and/or copying with disease by means of adapted and healthy lifestyles, possibly including informations on traditional and/or alternative medicines.

In/Out

Log in

Optional: Social Subscribe/Login

thasso: donate

We need your help. Please support the development of thasso through donations. Thank you. Nous avons besoin de votre aide. S'il vous plaît, vous pouvez soutenir le développement de thasso grâce à des dons. Merci. Wir brauchen Ihre Hilfe. Bitte unterstützen Sie die Entwicklung von thasso durch Spenden. Vielen Dank. Abbiamo bisogno del tuo aiuto. Si prega di sostenere lo sviluppo di thasso attraverso donazioni. Grazie. Nós precisamos da sua ajuda. Por favor, apoie o desenvolvimento de thasso através de doações. Obrigada. Necesitamos tu ayuda. Por favor apoye el desarrollo de thasso con donaciones. Muchas gracias.

Donate Thasso

We need your help; Nous avons besoin de votre aide. Wir brauchen ihre Hilfe. Abbiamo bisogno del tuo aiuto. Necesitamos tu ayuda.Precisamos da sua ajuda.

thasso: conditions

thasso: newest tweets

do_widget “Text”

FDA press releases

FDA Approves First Treatment for Children With Menkes Disease January 12, 2026
FDA Issues Guidance on Modernizing Statistical Methods for Clinical Trials January 12, 2026
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation January 11, 2026
FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products December 29, 2025
FDA Grants Two National Priority Vouchers December 19, 2025

FDA MedWatch

Anesthetic Vaporizer Recall: Draeger Removes Vapor 2000 and Vapor 3000 Vaporizers January 16, 2026
Early Alert: Broselow Rainbow Tape Issue from AirLife January 16, 2026
Olympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles January 16, 2026
Early Alert: Stent and Electrocautery-Enhanced Delivery System Issue from Boston Scientific January 16, 2026
Anesthesia Kit Recall: Medline Removes Anesthesia Circuits and Anesthesia Circuit Kits January 16, 2026

EMA Press releases

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 January 2026 January 16, 2026
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 12 - 15 January 2026 January 16, 2026
Human medicines in 2025 January 15, 2026
EMA and FDA set common principles for AI in medicine development January 14, 2026
Emer Cooke, EMA’s Executive Director: 2025 achievements in medicine regulation December 19, 2025

random genetics

Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics January 17, 2026
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers from Genomill Health Inc., the University of Turku, and the TYKS Turku University Hospital, Finland, benchmarked this new method, Bridge Capture, against two […]
National genomic screening program could save thousands of Australians from preventable cancer and heart disease January 17, 2026
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands of Australians from conditions like cancer and heart disease.
Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome January 16, 2026
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.
Alternative RNA splicing tied to schizophrenia-like behaviors in animal models January 16, 2026
In a new study, Chinese researchers have discovered the previously unrecognized role of alternative splicing of the DOC2A gene in schizophrenia.
Research reveals clues as to why standard antidepressants fail for so many January 16, 2026
A study from the University of Sydney's Brain and Mind Center reveals new clues as to why standard antidepressants fail for many Australians, opening the door for more effective, personalized treatments.

Recent Comments

Joseph Gut - thasso on Alzheimer’s: Are we at the beginning of a new era of treatment?: “Finally, Leqembi has now also been approved by the EMA. See https://www.ema.europa.eu/en/medicines/human/EPAR/leqembi#product-info” Jun 23, 08:12
20urbain05 on Orofacial clefts: Can genetic variants reveal how they arise?: “It would be of particular interest, which of the many existing sequence variants of the DDX1 gene is (are) particularly…” Apr 19, 13:33
20justin03 on Molecular differences in pancreatic cancer of patients with Caucasian or African Ethnicity: “Some new knowledge on the aggressivity of pancreatic cancer. Not yet known if this mechanism is more active in some…” Apr 17, 15:43
Joseph Gut - thasso on Semagludite: The cause for NAION and Blood Clots?: “NAION is slowly developing into a case for legal actions, according to Tom Lamb at Drug Injury Watch. https://www.drug-injury.com” Apr 10, 13:48
Joseph Gut - thasso on Molecular differences in pancreatic cancer of patients with Caucasian or African Ethnicity: “Newest research: New hope for patients with pancreatic cancer? https://medicalxpress.com/news/2025-04-proof-concept-approach-pancreatic-cancer.html” Apr 9, 14:02

Tag Cloud

Adverse Drug Reaction (ADR) African American Allelic Variant Allelic Variants American Food & Drug Administration (FDA) American Food & Drug Administration (FDA) Biomarker Boxed Warning Breast Cancer Canagliflozin (Invokana) Cancer Children Committee for Medicinal Products for Human Use (CHMP) Companion Test Covid-19 Covid-19 Disease Diabetes Drug Induced Liver Injury (DILI) Ethnicity European Medicines Agency (EMA) Food and Drug Administration (FDA) Gene Therapy Genetic Background Genetic Predisposition Genetic Testing Health Canada Non-Small Cell Lung Cancer (NSCLC) Obesity Pembrolizumab [Keytruda] Personalized Medicine Phenotype Progressive Multifocal Leukoencephalopathy (PML) Rare Disease Rare Genetic Disease Risk Evaluation and Mitigation Strategy (REMS) SARS-CoV-2 Schizophrenia Stevens Johnson Syndrome [SJS] Targeted Therapy ThassoBase Thasso Post Theragenomic Medicine Toxic Epidermal Necrolysis (TEN) Type 2 Diabetes Vemurafenib [Zelboraf]

Footer Menu

english
thasso
thasso post
thasso toolbox
thasso academy
thasso community
thasso: about
donations

Footer Menu

english
thasso
thasso post
thasso toolbox
thasso academy
thasso community
thasso: about
donations

Copyright © 2026 Thasso | Powered by Responsive Theme

Copyright © 2026 Thasso | Powered by Responsive Theme